Applications of diffusion-perfusion magnetic resonance imaging in acute ischemic stroke

Neurology

Volumn 52, Issue 9, 1999, Pages 1750-1756

  Fisher, Marc ^a,c   Albers, Gregory W ^b  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b University Medical Center   (United States)

^c University of Massachusetts   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN EDEMA; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW;

EID: 0032975092     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.9.1750     Document Type: Review

References (53)

1. Lodder J. CT-detected hemorrhagic infarction; relation with the size of the infarct and the presence of midline shift. Acta Neurol Scand 1984;70:329-335.
2. von Kummer R, Nolte PN, Schnittger H, Thron A, Ringelstein EB. Detectability of hemispheric infarction by computed tomography within 6 hours after stroke. Neuroradiology 1996; 38:31-33.
3. Tomsick TA. Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery. AJNR Am J Neuroradiol 1994;15:16-18.
4. von Kummer R, Allen KL, Holle R, et ai. Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology 1997;205:327-333.
5. Hacke W, Kaste M, Fieschi C, et al. Randomized double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemie stroke (ECASSII). Lancet 1998;352:1245-1251.
6. Yuh WTC, Grain MR, Loes DJ, et al. MR imaging of cerebral ischemia: findings in the first 24 hours. AJNR Am J Neuroradiol 1991;12:621-629.
7. Baird AE, Warach S. Magnetic resonance imaging of acute stroke. J Cereb Blood Flow Metab 1998;18:583-609.
8. Hoehn-Berlage M, Norris DG, Kohno K, et al. Evolution of regional changes in apparent diffusion coefficient during focal ischemia of rat brain: the relationship of quantitative diffusion
9. NMR imaging to reduction of cerebral blood flow and metabolic disturbances. J Cereb Blood Flow Metab 1995;15:1002-1011.
10. Verheul HB, Balazs R, Berkelbach M, et al. Comparison of diffusion-weighted MRI with changes in cell volume in a rat model of brain injury. NMR Biomed 1994;7:96-100.
11. Duong TQ, Ackerman JJH, Ying HS, Neil JJ. Evaluation of extra and intracellular apparent diffusion in normal and globally ischemie rat brain via 19FNMR. Magn Reson Med 1998;40:1-13.
12. Edelman RR, Wielpolski P, Schmitt F. Echo-planar imaging. Radiology 1994;192:600-612.
13. Albers GW, Lansberg MG, Norbash AM, et al. Yield of diffusion-weighted MRI for detecting clinically relevant findings in stroke patients. Stroke 1999;30:235. Abstract.
14. Detre JA, Leight JS, Williams DS, Koretsky AP. Perfusion imaging. Magn Reson Med 1992;22:37-45.
15. Rosen BR, Aronen HJ, Buchbinder B, et al. Advances in clinical neuroimaging: functional MR imaging techniques. Radiographics 1993;13:889-896.
16. Detre JA, Alsop DC, Vives LR, et al. Noninvasive MRI evaluation of cerebral blood flow in cerebrovascular disease. Neurology 1998;50:633-641.
17. Belliveau JW, Kennedy DN, McKinstry RC, et al. Functional mapping of the human visual cortex by magnetic resonance imaging. Science 1991;254:716-719.
18. Hamberg LM, MacFarlane R, Tasdemiroglu E, et al. Measurement of cerebrovascular changes in cats after transient ischemia using dynamic magnetic resonance imaging. Stroke 1993; 24:444-451.
19. Sorenson AG, Buonanno FS, Gonzalaez RG, et al. Hyperacute stroke: evaluation with combined multisection diffusionweighted and hemodynamically weighted echoplanar MR imaging. Radiology 1996;199:391-401.
20. Sorensen A, Tievsky A, Ostergaard L, Weisskoff R, Rosen B. Contrast agents in functional MR imaging. J Magn Reson Imaging 1997;7:47-55.
21. Guckel FJ, Brix G, Schmiedek P, et al. Cerebrovascular reserve capacity in patients with occlusive cerebrovascular disease: assessment with dynamic susceptibility contrastenhanced MR imaging and the acetazolamide stimulation test. Radiology 1996;201:405-412.
22. Schwamm LH, Koroshetz WJ, Sorenson G, et al. Time course of lesion development in patients with acute stroke: serial diffusion- and hemodynamic-weighted magnetic resonance imaging. Stroke 1998;29:2277-2284.
23. Li F, Han S, Tatlisumak T, et al. A new method to improve in-bore middle cerebral artery occlusion in rats: demonstration with diffusion and perfusion-weighted imaging. Stroke 1998;29:1715-1720.
24. Miyabe M, Mori S, van Zjil PCM, et al. Correlation of the average water diffusion constant with cerebral blood flow and ischemie damage after transient middle cerebral artery occlusion in cats. J Cereb Blood Flow Metab 1996;16:881-891.
25. Warach S, Chen D, Li W, Ronthal M, Edelman RR. Fast magnetic resonance imaging of acute human stroke. Neurology 1992;42:1717-1723.
26. Baird AE, Benfield A, Schlaug G, et al. Enlargement of human cerebral ischemie lesion volumes measured by diffusionweighted magnetic resonance imaging. Ann Neurol 1997;41: 581-589.
27. Singer MB, Chong J, Lu D, et al. Diffusion-weighted MRI in acute subcortical stroke. Stroke 1998;29:133-136.
28. Scarabino T, Carriero A, Magarelli N, et al. MR angiography in carotid stenosis: a comparison of three techniques. Eur J Radiol 1998;28:117-125.
29. Barboriak DP, Provenzale JM. MR arteriography of intracranial circulation. AJR Am J Roentgenol 1998;171:1469-1478.
30. Patel MR, Edelman RR, Warach S. Detection of hyperacute primary intraparenchymal hemorrhage by magnetic resonance imaging. Stroke 1996;27:2321-2324.
31. Warach S, Dashe JF, Edelman RR. Clinical outcome in ischemie stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis. J Cereb Blood Flow Metab 1996;16:53-59.
32. Tong DC, Yenari MA, Albers GW, O'Brien M, Marks MP, Moseley ME. Correlation of perfusion-weighted MRI with NIHSS score in acute (5 hour) ischemie stroke. Neurology 1998;50:864-870.
33. Lovblad K-O, Baird AE, Schlaug G, et al. Ischemie lesion volumes in acute stroke by diffusion weighted MRI study correlates with clinical outcome. Ann Neurol 1997;42:164-170.
34. Warach S, Pettigrew LG, Dashe JF. The effect of citicoline on lesion volume in acute stroke: a multicenter, double-blind, placebo-controlled trial. Stroke 1999;30:243. Abstract.
35. O'Brien MW, Ali J, Lansberg MG, et al. Evolution of human cerebral ischemie lesion volume studied by serial diffusion weighted magnetic resonance imaging. Neurology 1998; 50(suppl 4):A403. Abstract.
36. Hasegawa Y, Fisher M, Latour LL, Dardzinski BJ, Sotak CH. MRI diffusion mapping of reversible and irreversible ischemie injury in focal brain ischemia. Neurology 1994;44:1484-1490.
37. Carano RAD, Takano K, Holmer KG, et al. Determination of focal ischemie lesion volume in the rat brain using multispectral analysis. J Magn Reson Imaging 1998;8:1266-1278.
38. Lutsep HL, Albers GW, DeCrespigny A, Kamat GN, Marks MP, Moseley ME. Clinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemie stroke. Ann Neurol 1997;41:574-580.
39. Gonzalez RG, Schaefer PW, Buonanno F, et al. Diffusionweighted MR imaging: diagnostic accuracy within 6 hours of stroke onset. Radiology 1999;210:155-162.
40. Bollen J, Lodder J. Lacunar infarcts: pathogenesis and validity of the clinical syndrome. Stroke 1991;22:1374-1378.
41. Takano K, Tatlisumak T, Formato J, et al. A glycine site antagonist attenuates infarct size in experimental focal ischemia: postmortem and diffusion mapping studies. Stroke 1997; 28:1255-1263.
42. Lo EH, Pierce AR, Mandeville JB, Rosen BR. Neuroprotection with NBQX in rat focal cerebral ischemia: effects on ADC probability distribution functions and diffusion-perfusion relationships. Stroke 1997;28:439-447.
43. Qiu H, Hedlund LW, Gewalt SL, et al. Progression of a focal ischemie lesion in rat brain during treatment with a novel glycine/NMDA antagonist: an in vivo three-dimensional diffusion-weighted MR microscopy study. J Magn Reson Imaging 1997:7:739-744.
44. Takano T, Carano RAD, Tatlisumak T, et al. The efficacy of intraarterial and intravenous prourokinase in an embolie stroke model evaluated by diffusion-perfusion magnetic resonance imaging. Neurology 1998;50:870-875.
45. Jiang Q, Zhang RL, Zhang ZG, et al. Diffusion-, T2- and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolie stroke and recombinant tissue plasminogen activator intervention in the rat. J Cereb Blood Flow Metab 1998;18:758-767.
46. Stys PK. Anoxic and ischemie injury of myelinated axons in CNS white matter: from mechanistic concepts to therapeutics. J Cereb Blood Flow Metab 1998;18:2-25.
47. Minematsu K, Fisher M, Li L, Sotak CH. Diffusion and perfusion magnetic resonance imaging studies to evaluate a noncompetitive AT-methyl-D-aspartate antagonist and reperfusion in experimental stroke in rats. Stroke 1993;24:2074-2081.
48. Heiss WD, Grond M, Thiel A, et al. Tissue at risk of infarction rescued by early reperfusion: a positron emission tomography study in systemic recombinant tissue plasminogen activator thrombolysis of acute stroke. J Cereb Blood Flow Metab 1998; 18:1298-1307.
49. Alexandrov A, Masdev J, Devbus MD, Black SE, Grotta JC. Brain single photon emission CT with HMPAO and safety of thrombolytic therapy in acute ischemie stroke. Stroke 1997; 28:1830-1834.
50. Marks MP, Tong D, Beaulieu C, Albers GA, deCrespigny A, Moseley ME. Effective early reperfusion and intravenous tPA therapy on diffusion and perfusion-weighted MRI. Stroke 1999;30:235. Abstract.
51. Schlaug G, Benfield A, Siewart B, et al. The ischemie penumbra of human stroke: using functional MRI parameters to define tissue at risk for infarct progression. Neurology 1997; 48(suppl 2):A204. Abstract.
52. Firlik AD, Rubin G, Yonas H, Wechsler LR. Cerebral blood flow and neurologic deficit resolution in acute ischemie stroke. Neurology 1998;51:177-182.
53. Hunter GJ, Hamberg LM, Ponzo JA, et al. Assessment of cerebral perfusion and arterial anatomy in hyperacute stroke with three-dimensional functional CT: early results. AJNR Am J Neuroradiol 1998;19:29-37.